Biotech · Private company
Sensorion
Track this companyFree. Adds Sensorion to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- SENS-111 100mgPhase 2 · Acute Unilateral Vestibulopathy (AUV)ClinicalTrials.gov · fetched Nov 12, 2026
- SENS-111 200mgPhase 2 · Acute Unilateral Vestibulopathy (AUV)ClinicalTrials.gov · fetched Nov 12, 2026
- Audiological assessmentsSensorineural Hearing Loss, BilateralClinicalTrials.gov · fetched Nov 12, 2026
- GenotypingSensorineural Hearing Loss, BilateralClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Cross-sectional and Prospective Study to Characterize Early-onset PresbycusisTERMINATED · started Jun 14, 2024ClinicalTrials.gov NCT06354010 · fetched Nov 12, 2026
- Efficacy of SENS-111 in Patients Suffering From Acute Unilateral VestibulopathyPHASE2 · COMPLETED · started Aug 16, 2017ClinicalTrials.gov NCT03110458 · fetched Nov 12, 2026